Arcutis Biotherapeutics, Inc. ARQT Available For Sale Securities Debt Securities Current
Available For Sale Securities Debt Securities Current at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s available for sale securities debt securities current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s available for sale securities debt securities current?
- Arcutis Biotherapeutics, Inc. (ARQT) reported available for sale securities debt securities current of $189.24M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s available for sale securities debt securities current changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s available for sale securities debt securities current increased by 30.5% year-over-year, from $144.98M to $189.24M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s available for sale securities debt securities current?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s available for sale securities debt securities current has grown at a -4.1% compound annual growth rate (CAGR), from $219.36M to $178.08M.